Acoustic Medicine and Ultrasound Therapy Market Size, Share and Growth Outlook, 2026

Acoustic Medicine and Ultrasound Therapy Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Acoustic Medicine and Ultrasound Therapy Market size is forecast to increase from $2.33 Billion in 2026 to $3.66 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

The Acoustic Medicine and Ultrasound Therapy market report provides detailed analysis and outlook of Acoustic Medicine and Ultrasound Therapy segments including By Technology (Diagnostic Ultrasound Systems, Therapeutic Ultrasound Systems), By Modality (Bench-top Systems, Hand-held Systems, Portable / Wearable Systems), By Portability (Trolley / Cart-Based Systems, Compact / Handheld Systems), By Application (Osteoarthritis, Sports Injuries, Musculoskeletal Disorders, Emergency Medicine, Cardiovascular Applications, Oncology & Urology Surgery), By End-User (Hospitals, Private Clinics, Physiotherapy & Rehabilitation Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Acoustic Medicine and Ultrasound Therapy Industry Overview

Expanding Role of Focused Ultrasound in Non-Invasive Therapeutics

The Acoustic Medicine and Ultrasound Therapy industry is advancing rapidly as healthcare providers increasingly adopt focused ultrasound technologies for non-invasive treatment of oncological, neurological, musculoskeletal, and chronic pain conditions. The sector is moving beyond traditional ultrasound applications toward targeted therapeutic platforms capable of delivering precise acoustic energy to specific tissues without surgical intervention. Innovations in High-Intensity Focused Ultrasound (HIFU), Low-Intensity Focused Ultrasound (LIFU), wearable ultrasound therapy, and robotic guidance systems are broadening the clinical utility of acoustic medicine while supporting improved patient outcomes and reduced procedural invasiveness.

High-Intensity Focused Ultrasound Driving Oncology Innovation

A major trend within the industry is the growing use of HIFU technologies for cancer treatment and tissue ablation. EDAP TMS SA strengthened its position in the market after securing U.S. FDA 510(k) clearance for the latest workflow enhancements to its High-Intensity Focused Ultrasound platform. The updated system is designed to improve procedural efficiency and treatment planning capabilities for clinicians utilizing focused ultrasound therapies. In addition, EDAP TMS achieved an important clinical milestone by treating the first patient using its proprietary robotic HIFU technology for pancreatic cancer tumors. This development highlights the increasing application of robotic-assisted focused ultrasound systems in difficult-to-treat oncology indications, where precision targeting and minimally invasive treatment approaches are highly valued.

Open-Architecture Research Accelerating Neurological Applications

Research institutions and technology developers are increasingly collaborating to expand the therapeutic potential of acoustic medicine. Openwater initiated a strategic collaboration with the Sharma Lab at North Carolina State University and the University of North Carolina to deploy the Open-LIFU platform. This open-architecture initiative is focused on developing targeted Low-Intensity Focused Ultrasound solutions for non-invasive neurological therapies. The project supports multidisciplinary research into brain-related disorders and demonstrates the growing interest in ultrasound-based neuromodulation as an alternative to invasive treatment approaches. The open-source framework is expected to accelerate innovation by enabling broader research participation and technology development across academic and clinical environments.

Wearable Ultrasound Systems Expanding Chronic Pain Management

Wearable therapeutic ultrasound devices are becoming an increasingly important segment of the acoustic medicine market. ZetrOZ Systems received official Ease of Use® Certification from the Arthritis Foundation for its sam® 2.0 Wearable Ultrasound device. The platform remains the only FDA-cleared wearable system capable of delivering up to four hours of continuous low-intensity Sustained Acoustic Medicine therapy. Designed for long-duration treatment of chronic joint and soft-tissue pain, the device supports non-invasive pain management strategies while allowing patients to remain mobile during therapy. The growing demand for home-based and wearable therapeutic solutions continues to drive adoption of sustained acoustic medicine technologies across musculoskeletal care settings.

Standardization Efforts Strengthening Global Clinical Adoption

Industry-wide efforts are increasingly focused on establishing standardized treatment protocols and harmonized clinical practices. The Focused Ultrasound Foundation formally launched the International Focused Ultrasound Society to support global collaboration in the field of therapeutic ultrasound. The organization aims to unify clinical standards, promote knowledge sharing, and establish evidence-based treatment guidelines for neurological and oncological disorders treated with focused acoustic energy. These initiatives are expected to enhance clinical consistency, support regulatory advancement, and accelerate the integration of ultrasound-based therapies into mainstream medical practice.

Acoustic Medicine and Ultrasound Therapy Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Acoustic Medicine and Ultrasound Therapy market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, EDAP TMS S.A., Guided Therapy Systems, LLC, Misonix, Inc. (Bioventus LLC), InSightec Ltd., BTL Industries, Inc., Chatanooga (Enovis / DJO Global), GymnaUniphy N.V.. The Acoustic Medicine and Ultrasound Therapy market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Acoustic Medicine and Ultrasound Therapy industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Acoustic Medicine and Ultrasound Therapy Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Acoustic Medicine and Ultrasound Therapy companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Acoustic Medicine and Ultrasound Therapy markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Acoustic Medicine and Ultrasound Therapy Market Competitive Benchmarking and Company Analysis

Leading companies in Acoustic Medicine and Ultrasound Therapy industry include- GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, EDAP TMS S.A., Guided Therapy Systems, LLC, Misonix, Inc. (Bioventus LLC), InSightec Ltd., BTL Industries, Inc., Chatanooga (Enovis / DJO Global), GymnaUniphy N.V.. The Acoustic Medicine and Ultrasound Therapy market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Acoustic Medicine and Ultrasound Therapy Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Acoustic Medicine and Ultrasound Therapy market remains one of the strongest-performing segments in the country.
The US Acoustic Medicine and Ultrasound Therapy Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Acoustic Medicine and Ultrasound Therapy market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Acoustic Medicine and Ultrasound Therapy industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Acoustic Medicine and Ultrasound Therapy markets

Canada's strong Acoustic Medicine and Ultrasound Therapy sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Acoustic Medicine and Ultrasound Therapy market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Acoustic Medicine and Ultrasound Therapy Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Acoustic Medicine and Ultrasound Therapy market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Acoustic Medicine and Ultrasound Therapy population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Acoustic Medicine and Ultrasound Therapy industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Acoustic Medicine and Ultrasound Therapy market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Acoustic Medicine and Ultrasound Therapy sales through 2034

France Acoustic Medicine and Ultrasound Therapy companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Acoustic Medicine and Ultrasound Therapy Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Acoustic Medicine and Ultrasound Therapy distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Acoustic Medicine and Ultrasound Therapy Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Acoustic Medicine and Ultrasound Therapy market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Acoustic Medicine and Ultrasound Therapy industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Acoustic Medicine and Ultrasound Therapy industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Acoustic Medicine and Ultrasound Therapy Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Acoustic Medicine and Ultrasound Therapy market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Acoustic Medicine and Ultrasound Therapy market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Acoustic Medicine and Ultrasound Therapy Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Acoustic Medicine and Ultrasound Therapy Market Segmentation

By Technology
Diagnostic Ultrasound Systems
Therapeutic Ultrasound Systems
By Modality
Bench-top Systems
Hand-held Systems
Portable / Wearable Systems
By Portability
Trolley / Cart-Based Systems
Compact / Handheld Systems
By Application
Osteoarthritis
Sports Injuries
Musculoskeletal Disorders
Emergency Medicine
Cardiovascular Applications
Oncology & Urology Surgery
By End-User
Hospitals
Private Clinics
Physiotherapy & Rehabilitation Centers

Top Companies in Acoustic Medicine and Ultrasound Therapy Industry

GE HealthCare
Koninklijke Philips N.V.
Siemens Healthineers AG
EDAP TMS S.A.
Guided Therapy Systems, LLC
Misonix, Inc. (Bioventus LLC)
InSightec Ltd.
BTL Industries, Inc.
Chatanooga (Enovis / DJO Global)
GymnaUniphy N.V.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025